OxyContin reformulated to deter abuse

OxyContin reformulated to deter abuse was a 2010 change to Purdue Pharma’s opioid painkiller intended to make the tablets more difficult to misuse. In the book’s account, its significance lies in the gap between altering a drug’s formulation and ending dependence: some users could no longer manipulate the pills as before, while people who had relied on them turned to other sources, including heroin.

Before the reformulation

Before the 2010 change, OxyContin and other prescription pills were circulating among young people in Roanoke’s northern suburbs through informal networks. Teenagers in Hidden Valley called the green 80-milligram tablets Green Goblins. They obtained them from sources that included a restaurant coworker, a brother prescribed pills after wisdom-tooth surgery, and a veteran who passed along medication left over from a legitimate pain prescription. The routes into use could therefore run through friends, family, work, and medical prescribing rather than through a street dealer alone.

That suburban pattern differed from the older image of heroin in Roanoke. Don Wolthuis recalled that, in the 1980s and 1990s, only a few dozen people in the area used heroin, and that the drug was widely associated with a small, mostly Black, inner-city population. Heroin use was comparatively hard for the wider community to see. By contrast, prescription pills moved through peer groups in places where families and authorities might not recognize what was happening. In the book’s account, the eventual change in pill availability unfolded against these differing patterns of visibility and access.

What changed in 2010

Purdue Pharma introduced an abuse-resistant version of OxyContin in 2010. The reformulation followed a campaign by Barbara Van Rooyan, who had petitioned the Food and Drug Administration for an opioid antagonist to be added to the drug. A suburban user identified as Victoria recalled that when she tried to crush the reformulated tablets, they gelled, preventing the methods she had expected to use. For her, the change marked a practical break: pills either became unavailable or too expensive, and people who had dealt pills began dealing heroin instead.

The reformulation coincided with a wider transition in the Roanoke area. Purdue’s new version arrived fourteen years after OxyContin’s introduction and at roughly the time that police were beginning to encounter suburban users more often. The book places this change alongside the movement of opioid use through teenagers’ and young adults’ social networks; it does not present the new formulation as a single explanation for the epidemic, but documents it as a turning point in how some users and sellers obtained opioids.

From pills to heroin

Ashlyn Keikilani Kessler’s experience shows a related sequence. After becoming dependent on prescription opioids following childbirth, she moved from OxyContin to Roxicodone when the reformulated OxyContin appeared. When black-market Roxicodone became more expensive and harder to obtain, she switched to heroin. She described the progression from OxyContin to Roxicodone to heroin as a pattern she saw among many people. Her account also preserves a distinction in perceived risk: she preferred pills because their contents seemed more predictable than heroin’s.

The change in supply did not stop at individual users. Since the 2010 reformulation, officer Brent Lutz had followed a small group of mostly young white men who drove about two hours from the Roanoke region to Baltimore, bought heroin for their own use and extra to sell to friends, and used the proceeds to finance the next trip. Police classified them as commuter-dealers. Their activity connected suburban demand to a much larger market: heroin sales in Baltimore were estimated at $1.5 million a day, and the city’s established routes included Interstate 95, known as the Heroin Highway. The reformulation thus appears in the book within a changing supply chain, not as a barrier that simply made opioid use disappear.

The wider crisis and its unequal burdens

The move from pills to heroin took place within systems that offered uneven responses to addiction. In 2014, Centers for Disease Control and Prevention data showed that doctors prescribed painkillers to people of color at much lower rates than to white patients, in part because of mistrust and assumptions about misuse. At the same time, the book contrasts the response to many white opioid users, whose dealing or property offenses were often discussed as part of a public-health crisis, with the continued imprisonment of Black and Hispanic people for drug offenses. These differences do not establish that the reformulation itself produced racial disparities; they show that the shift in drug supply occurred within already unequal systems of prescribing and punishment.

The scale of the crisis also exposed gaps between criminal justice and health care. In 2012, families confronting heroin use in the Roanoke suburbs often lacked even informal networks for sharing treatment advice and practical support. A later effort at the Bradley Free Clinic tried to connect people with treatment through trained volunteers, but local organizers faced shortages of medication-assisted-treatment providers, detox capacity, and residential beds. These later pressures are part of the aftermath surrounding the shift from prescription pills to heroin: changing the tablet altered one route of misuse, while families, health workers, and police were left confronting a broader and more difficult problem.